Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125883341 | 12588334 | 1 | I | 20160513 | 20160516 | 20160725 | 20160725 | PER | US-JNJFOC-20160516051 | JANSSEN | 62.00 | YR | A | F | Y | 81.19000 | KG | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125883341 | 12588334 | 1 | PS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 1 TABLET, 2X IN 24 HOURS | N | 452563 | 19835 | 10 | MG | TABLET | |||||
| 125883341 | 12588334 | 2 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 1 TABLET, 2X IN 24 HOURS | N | 452563 | 19835 | 10 | MG | TABLET | |||||
| 125883341 | 12588334 | 3 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | YEARS | 0 | UNSPECIFIED | |||||||||
| 125883341 | 12588334 | 4 | C | BABY ASPIRIN | ASPIRIN | 1 | Unknown | 0 | 81 | MG | UNSPECIFIED | QD | |||||||
| 125883341 | 12588334 | 5 | C | FISH OIL | FISH OIL | 1 | Unknown | YEARS | 0 | UNSPECIFIED | |||||||||
| 125883341 | 12588334 | 6 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Unknown | 2 SPRAY EACH NOSTRIL | 0 | UNSPECIFIED | |||||||||
| 125883341 | 12588334 | 7 | C | VITAMIN C | ASCORBIC ACID | 1 | Unknown | 2-3 PER DAY, 3 YEARS | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125883341 | 12588334 | 1 | Middle ear effusion |
| 125883341 | 12588334 | 2 | Dizziness |
| 125883341 | 12588334 | 3 | Blood cholesterol increased |
| 125883341 | 12588334 | 4 | Anticoagulant therapy |
| 125883341 | 12588334 | 5 | Nutritional supplementation |
| 125883341 | 12588334 | 6 | Middle ear effusion |
| 125883341 | 12588334 | 7 | Nutritional supplementation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125883341 | 12588334 | Dizziness | |
| 125883341 | 12588334 | Off label use | |
| 125883341 | 12588334 | Overdose | |
| 125883341 | 12588334 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125883341 | 12588334 | 1 | 20160513 | 0 | ||
| 125883341 | 12588334 | 2 | 20160513 | 0 | ||
| 125883341 | 12588334 | 6 | 20160515 | 0 |